vs

Side-by-side financial comparison of CIENA CORP (CIEN) and Insulet Corporation (PODD). Click either name above to swap in a different company.

CIENA CORP is the larger business by last-quarter revenue ($1.2B vs $783.7M, roughly 1.6× Insulet Corporation). Insulet Corporation runs the higher net margin — 13.0% vs 4.1%, a 8.8% gap on every dollar of revenue. CIENA CORP produced more free cash flow last quarter ($134.6M vs $48.2M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs 3.9%).

Ciena Corporation is an American optical networking systems and software company based in Hanover, Maryland. The company has been described as a vital player in optical connectivity. The company reported revenues of $4.8 billion and more than 9,000 employees, as of November 2025. Gary Smith serves as president and chief executive officer (CEO).

An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.

CIEN vs PODD — Head-to-Head

Bigger by revenue
CIEN
CIEN
1.6× larger
CIEN
$1.2B
$783.7M
PODD
Higher net margin
PODD
PODD
8.8% more per $
PODD
13.0%
4.1%
CIEN
More free cash flow
CIEN
CIEN
$86.4M more FCF
CIEN
$134.6M
$48.2M
PODD
Faster 2-yr revenue CAGR
PODD
PODD
Annualised
PODD
33.2%
3.9%
CIEN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CIEN
CIEN
PODD
PODD
Revenue
$1.2B
$783.7M
Net Profit
$50.3M
$101.6M
Gross Margin
41.3%
72.6%
Operating Margin
6.0%
18.7%
Net Margin
4.1%
13.0%
Revenue YoY
31.2%
Net Profit YoY
0.9%
EPS (diluted)
$0.35
$1.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIEN
CIEN
PODD
PODD
Q4 25
$783.7M
Q3 25
$1.2B
$706.3M
Q2 25
$1.1B
$649.1M
Q1 25
$1.1B
$569.0M
Q4 24
$1.1B
$597.5M
Q3 24
$942.3M
$543.9M
Q2 24
$910.8M
$488.5M
Q1 24
$1.0B
$441.7M
Net Profit
CIEN
CIEN
PODD
PODD
Q4 25
$101.6M
Q3 25
$50.3M
$87.6M
Q2 25
$9.0M
$22.5M
Q1 25
$44.6M
$35.4M
Q4 24
$37.0M
$100.7M
Q3 24
$14.2M
$77.5M
Q2 24
$-16.8M
$188.6M
Q1 24
$49.5M
$51.5M
Gross Margin
CIEN
CIEN
PODD
PODD
Q4 25
72.6%
Q3 25
41.3%
72.2%
Q2 25
40.2%
69.7%
Q1 25
44.0%
71.9%
Q4 24
40.9%
72.1%
Q3 24
42.9%
69.3%
Q2 24
42.7%
67.7%
Q1 24
45.0%
69.5%
Operating Margin
CIEN
CIEN
PODD
PODD
Q4 25
18.7%
Q3 25
6.0%
16.7%
Q2 25
2.9%
18.7%
Q1 25
7.5%
15.6%
Q4 24
5.3%
18.3%
Q3 24
2.8%
16.2%
Q2 24
-0.4%
11.2%
Q1 24
8.2%
12.9%
Net Margin
CIEN
CIEN
PODD
PODD
Q4 25
13.0%
Q3 25
4.1%
12.4%
Q2 25
0.8%
3.5%
Q1 25
4.2%
6.2%
Q4 24
3.3%
16.9%
Q3 24
1.5%
14.2%
Q2 24
-1.8%
38.6%
Q1 24
4.8%
11.7%
EPS (diluted)
CIEN
CIEN
PODD
PODD
Q4 25
$1.42
Q3 25
$0.35
$1.24
Q2 25
$0.06
$0.32
Q1 25
$0.31
$0.50
Q4 24
$0.26
$1.38
Q3 24
$0.10
$1.08
Q2 24
$-0.12
$2.59
Q1 24
$0.34
$0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIEN
CIEN
PODD
PODD
Cash + ST InvestmentsLiquidity on hand
$1.3B
Total DebtLower is stronger
$930.8M
Stockholders' EquityBook value
$2.8B
$1.5B
Total Assets
$5.7B
$3.2B
Debt / EquityLower = less leverage
0.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIEN
CIEN
PODD
PODD
Q4 25
Q3 25
$1.3B
Q2 25
$1.3B
Q1 25
$1.2B
Q4 24
$1.3B
Q3 24
$1.1B
Q2 24
$1.3B
Q1 24
$1.4B
Total Debt
CIEN
CIEN
PODD
PODD
Q4 25
$930.8M
Q3 25
$934.9M
Q2 25
$939.0M
Q1 25
$1.6B
Q4 24
$1.3B
Q3 24
$1.4B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
CIEN
CIEN
PODD
PODD
Q4 25
$1.5B
Q3 25
$2.8B
$1.4B
Q2 25
$2.8B
$1.5B
Q1 25
$2.8B
$1.3B
Q4 24
$2.8B
$1.2B
Q3 24
$2.9B
$1.1B
Q2 24
$2.9B
$998.4M
Q1 24
$2.9B
$790.7M
Total Assets
CIEN
CIEN
PODD
PODD
Q4 25
$3.2B
Q3 25
$5.7B
$3.0B
Q2 25
$5.7B
$3.5B
Q1 25
$5.6B
$3.5B
Q4 24
$5.6B
$3.1B
Q3 24
$5.6B
$3.0B
Q2 24
$5.6B
$2.9B
Q1 24
$5.6B
$2.6B
Debt / Equity
CIEN
CIEN
PODD
PODD
Q4 25
0.61×
Q3 25
0.68×
Q2 25
0.64×
Q1 25
1.21×
Q4 24
1.07×
Q3 24
1.21×
Q2 24
1.36×
Q1 24
1.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIEN
CIEN
PODD
PODD
Operating Cash FlowLast quarter
$174.3M
$183.3M
Free Cash FlowOCF − Capex
$134.6M
$48.2M
FCF MarginFCF / Revenue
11.0%
6.2%
Capex IntensityCapex / Revenue
3.3%
17.2%
Cash ConversionOCF / Net Profit
3.47×
1.80×
TTM Free Cash FlowTrailing 4 quarters
$605.5M
$377.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIEN
CIEN
PODD
PODD
Q4 25
$183.3M
Q3 25
$174.3M
$125.7M
Q2 25
$156.9M
$196.5M
Q1 25
$103.7M
$63.8M
Q4 24
$349.4M
$147.7M
Q3 24
$-159.4M
$98.5M
Q2 24
$58.5M
$96.5M
Q1 24
$266.1M
$87.6M
Free Cash Flow
CIEN
CIEN
PODD
PODD
Q4 25
$48.2M
Q3 25
$134.6M
$100.1M
Q2 25
$128.2M
$177.9M
Q1 25
$76.8M
$51.5M
Q4 24
$265.8M
$94.1M
Q3 24
$-179.0M
$71.8M
Q2 24
$41.6M
$74.0M
Q1 24
$249.5M
$65.5M
FCF Margin
CIEN
CIEN
PODD
PODD
Q4 25
6.2%
Q3 25
11.0%
14.2%
Q2 25
11.4%
27.4%
Q1 25
7.2%
9.1%
Q4 24
23.6%
15.7%
Q3 24
-19.0%
13.2%
Q2 24
4.6%
15.1%
Q1 24
24.0%
14.8%
Capex Intensity
CIEN
CIEN
PODD
PODD
Q4 25
17.2%
Q3 25
3.3%
3.6%
Q2 25
2.6%
2.9%
Q1 25
2.5%
2.2%
Q4 24
7.4%
9.0%
Q3 24
2.1%
4.9%
Q2 24
1.9%
4.6%
Q1 24
1.6%
5.0%
Cash Conversion
CIEN
CIEN
PODD
PODD
Q4 25
1.80×
Q3 25
3.47×
1.43×
Q2 25
17.50×
8.73×
Q1 25
2.33×
1.80×
Q4 24
9.44×
1.47×
Q3 24
-11.20×
1.27×
Q2 24
0.51×
Q1 24
5.37×
1.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CIEN
CIEN

Optical Networking$815.5M67%
Routing And Switching$125.9M10%
Platform Softwareand Services Segment$90.0M7%
Maintenance Support And Training$80.7M7%
Installation And Deployment$65.9M5%
Blue Planet Automation Softwareand Services Segment$27.8M2%
Consulting And Network Design$13.6M1%

PODD
PODD

U.S.Omnipod$567.8M72%
International Omnipod$214.0M27%
Drug Delivery$1.9M0%

Related Comparisons